Variant · Snv
NFATC1 NM_001278669.2(NFATC1):c.2289C>T (p.Gly763=)
CI-VAR-00228803Explore in graph →p.Gly763=NM_001278669.2:c.2289C>TClinVar 1602345 rs7233684
Curated evidence
Evidence by cancer (0 items)
Grouped by cancer context first, then therapy. The same variant can be sensitizing in one cancer and irrelevant in another — contexts are never merged. 50 items per page; a cancer group may continue on the next page.
Data not yet available
No curated evidence item references this variant yet.
ClinVar
Clinical significance (1)
ClinVar interpretations are shown as structured records — significance, review status, star rating, conditions — never flattened into one word.
clinvarProvenance
- Source
- NCBI ClinVar (variant_summary)
- Dataset
- ClinVar variant_summary
- Version
- 2026-09-06
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Evidence
- database
- License
- Public domain (US Government work, NCBI/NLM); acknowledgment requested
- Run
- ING-CLINVAR-20260908-000001
| Variation | Clinical significance | Review status | Stars | Conditions | Origin | Submitters | Last evaluated | Source |
|---|---|---|---|---|---|---|---|---|
| 1602345 | Benign | criteria provided, multiple submitters, no conflicts | 2 | Malignant lymphoma, large B-cell, diffuse; Colorectal cancer; NFATC1-related disorder; Thymoma; Cholangiocarcinoma; Nonpapillary renal cell carcinoma; Adrenocortical carcinoma, hereditary; Uterine corpus endometrial carcinoma; Colon adenocarcinoma | germline | 4 | Feb 01, 2026 | clinvar |